Pharma-Bio Serv (PBSV) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -35.29% |
| Oct 31, 2025 | -51.11% |
| Jul 31, 2025 | -17.77% |
| Apr 30, 2025 | -33.39% |
| Jan 31, 2025 | -55.95% |
| Oct 31, 2024 | -15.22% |
| Jul 31, 2024 | -21.57% |
| Apr 30, 2024 | -17.57% |
| Jan 31, 2024 | -20.13% |
| Oct 31, 2023 | -15.89% |
| Jul 31, 2023 | -5.39% |
| Apr 30, 2023 | 132.51% |
| Jan 31, 2023 | 20.26% |
| Oct 31, 2022 | 20.56% |
| Jul 31, 2022 | 31.65% |
| Apr 30, 2022 | 23.59% |
| Jan 31, 2022 | 24.05% |
| Oct 31, 2021 | -56.43% |
| Jul 31, 2021 | 84.94% |
| Apr 30, 2021 | 44.89% |
| Jan 31, 2021 | -3.36% |
| Oct 31, 2020 | -23.44% |
| Jul 31, 2020 | 9.70% |
| Apr 30, 2020 | 14.47% |
| Jan 31, 2020 | 12.21% |
| Jul 31, 2019 | -8.70% |
| Apr 30, 2019 | 13.35% |
| Jan 31, 2019 | -9.09% |
| Oct 31, 2018 | -18.85% |
| Jul 31, 2018 | -12.77% |
| Apr 30, 2018 | -14.93% |
| Jan 31, 2018 | -29.25% |
| Oct 31, 2017 | -42.09% |
| Jul 31, 2017 | -16.03% |
| Apr 30, 2017 | -17.36% |
| Jan 31, 2017 | -17.91% |
| Oct 31, 2016 | -20.07% |
| Jul 31, 2016 | -16.00% |
| Apr 30, 2016 | -42.92% |
| Jan 31, 2016 | -6.04% |
| Oct 31, 2015 | 15.72% |
| Jul 31, 2015 | 19.14% |